Incanthera (AQSE:INC) Selling and Marketing Expense: £0.00 Mil (TTM As of Sep. 2025)


What is Incanthera Selling and Marketing Expense?

Incanthera AQSE:INC Selling and Marketing Expense is £0.00 Mil as of Sep. 2025. The stock has 2 warning signs investors should review.

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Incanthera's Selling and Marketing Expense for the six months ended in Sep. 2025 was £0.00 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Sep. 2025 was £0.00 Mil.

Incanthera Selling and Marketing Expense Related Terms

Incanthera Selling and Marketing Expense Historical Data

* Premium members only.

The historical data trend for Incanthera's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Incanthera Selling and Marketing Expense Chart

Incanthera Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Selling and Marketing Expense
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Incanthera Semi-Annual Data
Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Incanthera Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Sep. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Selling and Marketing Expense of £0.00 Mil mean?
Incanthera (AQSE:INC) has a Selling and Marketing Expense of £0.00 Mil as of Sep. 2025. Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. View historical data on Incanthera and its competitors.
Is Incanthera's Selling and Marketing Expense too high?
Incanthera's current Selling and Marketing Expense is £0.00 Mil.
How does Incanthera's Selling and Marketing Expense compare to VRTX and REGN?
Incanthera's Selling and Marketing Expense of £0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Selling and Marketing Expense for a Biotechnology company?
A good Selling and Marketing Expense depends on the Biotechnology industry context. However, Selling and Marketing Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Selling and Marketing Expense mean?
A high Selling and Marketing Expense can signal that a stock is expensive relative to its fundamentals. Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. View historical data on Incanthera and its competitors. Incanthera's current Selling and Marketing Expense is £0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Incanthera stock overvalued right now?
Incanthera (AQSE:INC) has a current Selling and Marketing Expense of £0.00 Mil. The current Selling and Marketing Expense is £0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Selling and Marketing Expense calculated?
Selling and Marketing Expense is calculated from a company's financial statements. For Incanthera (AQSE:INC), the current Selling and Marketing Expense is £0.00 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Incanthera Business Description

Address C/o Gateley Plc, 98 King Street, Manchester, GBR, M2 4WU
Incanthera PLC is clinical stage drug development. It specializes in dermatology and oncology therapeutics. The company has launched a skincare range called Skin + CELL, which addresses and enhances life quality through effective delivery of bioactive ingredients capable of energising the skin's natural repair and defence processes at the cellular level. It has one reportable segment, namely the development of dermatology and pharmaceutical products, within the United Kingdom and Switzerland.